Anti-Thyroid Drugs Global Market Report 2021: COVID-19 Impact And Recovery To 2030
Anti-Thyroid Drugs Market Report 2021: COVID-19 Impact And Recovery To 2030
The Business Research Company’s Anti-Thyroid Drugs Global Market Report 2021: COVID-19 Impact and Recovery To 2030
LONDON, GREATER LONDON , UK, July 30, 2021 /EINPresswire.com/ — Graves’ disease is one of the direct causes of hyperthyroidism, and the incidence of Graves’ disease is increasing. In 2018, nearly 384,500 people were suffering from Graves’ disease in the seven major market across the globe and the USA accounted for the highest reported cases with a prevalence of 1.2%. Owing to the rising number of Grave’s disease, people suffering from hyperthyroidism is also increasing. This results in the overall growth in the thyroid gland disorders treatment market.
The anti-thyroid drugs market consists of sales of anti-thyroid drugs and related services which are used for the treatment of hyperthyroidism. Hyperthyroidism is caused by over production of thyroid hormones in children, adults, and pregnant women. The anti-thyroid class of drugs is also called thionamides, which block the formation of the thyroid hormone from an overactive thyroid gland.
Read More On The Anti-Thyroid Drugs Global Market Report:
https://www.thebusinessresearchcompany.com/report/anti-thyroid-drugs-global-market-report
The global anti-thyroid drugs market is expected to decline from $1.71 billion in 2020 to $1.5 billion in 2021 at a compound annual growth rate (CAGR) of -12.3%. The decline is mainly due to the companies rearranging their operations and recovering slowly from the COVID-19 impact. The anti-thyroid drugs market is expected to reach $1.73 billion in 2025 at a CAGR of 3.6%.
TBRC’s anti-thyroid drugs market report is segmented by drug type into thionamides (inhibition of hormone synthesis), iodides (inhibition of hormone release); by route of administration into oral, intravenous, others; by distribution channel into wholesaler/distributors, retail chain, online distribution, others.
Major players in the anti-thyroid drugs market are Mylan N.V., Abbott Laboratories, GlaxoSmithKline plc, Merck & Co. and AbbVie, Inc.
Anti-Thyroid Drugs Global Market Report 2021: COVID-19 Impact and Recovery To 2030 is one of a series of new reports from The Business Research Company that provides anti-thyroid drugs global market overview, forecast anti-thyroid drugs global market size and growth for the whole market, anti-thyroid drugs global market segments, and geographies, anti-thyroid drugs global market trends, anti-thyroid drugs market drivers, restraints, leading competitors’ revenues, profiles, and market shares.
Request For A Sample Of The Global Anti-Thyroid Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3401&type=smp
Here Is A List Of Similar Reports By The Business Research Company:
Thyroid Cancer Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030
https://www.thebusinessresearchcompany.com/report/thyroid-cancer-drugs-global-market-report
Metabolic Disorders Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030
https://www.thebusinessresearchcompany.com/report/metabolic-disorders-drugs-global-market-report-2020-30-covid-19-impact-and-recovery
Anti-Hypertensive Drugs Global Market Report 2021: COVID-19 Impact And Recovery To 2030
https://www.thebusinessresearchcompany.com/report/anti-hypertensive-drugs-global-market-report
Interested to know more about The Business Research Company?
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.
Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
The Business Research Company
Email: info@tbrc.info
Follow us on LinkedIn: https://bit.ly/3b7850r
Follow us on Twitter: https://bit.ly/3b1rmjS
Check out our Blog: http://blog.tbrc.info/
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn
